|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
48
|
|
pubmed:dateCreated |
2007-12-28
|
|
pubmed:abstractText |
To improve the results of New therapeutic strategies in hepatocellular carcinoma (HCC). We have conducted a phase II study with pegylated liposomal doxorubicin (PLD), 5-fluorouracil (5FU) and folinic acid (FA).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1007-9327
|
|
pubmed:author |
pubmed-author:CarlomagnoChiaraC,
pubmed-author:ChirianniAntonioA,
pubmed-author:De PlacidoSabinoS,
pubmed-author:De StefanoAlfonsoA,
pubmed-author:Di LorenzoGiuseppeG,
pubmed-author:EspositoVincenzoV,
pubmed-author:LabiancaRobertoR,
pubmed-author:MontesarchioVincenzoV,
pubmed-author:PalmieriGiovannellaG,
pubmed-author:PepeStefanoS,
pubmed-author:ReaAntonioA
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
28
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6553-7
|
|
pubmed:meshHeading |
pubmed-meshheading:18161926-Adult,
pubmed-meshheading:18161926-Aged,
pubmed-meshheading:18161926-Aged, 80 and over,
pubmed-meshheading:18161926-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18161926-Carcinoma, Hepatocellular,
pubmed-meshheading:18161926-Disease Progression,
pubmed-meshheading:18161926-Doxorubicin,
pubmed-meshheading:18161926-Drug Administration Schedule,
pubmed-meshheading:18161926-Drug Therapy, Combination,
pubmed-meshheading:18161926-Female,
pubmed-meshheading:18161926-Fluorouracil,
pubmed-meshheading:18161926-Follow-Up Studies,
pubmed-meshheading:18161926-Humans,
pubmed-meshheading:18161926-Leucovorin,
pubmed-meshheading:18161926-Liver Neoplasms,
pubmed-meshheading:18161926-Male,
pubmed-meshheading:18161926-Middle Aged,
pubmed-meshheading:18161926-Polyethylene Glycols,
pubmed-meshheading:18161926-Treatment Outcome,
pubmed-meshheading:18161926-Vitamin B Complex
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study.
|
|
pubmed:affiliation |
Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Universita degli Studi Federico II, Naples, Italy. giuseppedilorenzoncol@hotmail.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II
|
